Wiam Bshara

Additional file 3: Table S1. of Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing

Jianmin Wang, Lei Wei, Antonios Papanicolau-Sengos, 2016 .

A four gene signature predictive of recurrent prostate cancer

Wiam Bshara, Carl Morrison, James L Mohler, 2016, Oncotarget.

PRAME expression and promoter hypomethylation in epithelial ovarian cancer

Kevin H. Eng, Angela Omilian, Wiam Bshara, 2016, Oncotarget.

Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer

Pengyuan Liu, Song Liu, Ming You, 2014, Proceedings of the National Academy of Sciences.

Frequency of breast cancer subtypes among African American women in the AMBER consortium

Zhiyuan Hu, Yan Li, Melissa A. Troester, 2018, Breast Cancer Research.

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Steven M. Anderson, Mark Gardner, Laura J. Tafe, 2018, Journal of Immunotherapy for Cancer.

Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors.

Mark Gardner, Fiona C L Hyland, Blake Burgher, 2018, The Journal of molecular diagnostics : JMD.

Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification

Melissa A. Troester, Mark E. Sherman, Andrew F. Olshan, 2016, Breast Cancer Research.

High focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotype

Elizabeth Brese, Wiam Bshara, Carl Morrison, 2014, BMC Cancer.